Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 1998

View Archived Issues

Hypoglycemic effects of the alpha2-adrenoceptor antagonists SL-84.0418 and deriglidole

T-794: a MAO-A inhibitor with antidepressant activity

Evaluation of combination therapy for the treatment of erectile dysfunction

Effects of aspirin + ticlopidine combination antiplatelet therapy following stent implantation

Genentech: Q1 1998 highlights

Idun seeks licensing partners for apoptosis regulators

Sertraline: a selective serotonin reuptake inhibitor for the treatment of PMDD

New endothelin antagonists from Bristol-Myers Squibb

Synthetic dolastatin derivatives as antitumor agents

Akorn acquires ophthalmic products from Alza

Company Profile: Ixion Biotechnology

Fujisawa-Fisons to promote respiratory product in Japan

Alza acquires Canadian rights to Ditropan

Schering-Plough seeks FDA approval for Intron A combination

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

Novel cell adhesion inhibitors discovered at Biogen

Chiesi prepares new anticonvulsants and neuroprotective agents

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

Conjugates for imaging vascular thrombi developed at NeoRx/U. of Washington

First launch for topical biologic that helps heal diabetic foot ulcers

Potential preventive HIV vaccine shows promise in preclinical studies

RPR's Gliadel Wafer approved in Argentina

Abbott acquires control of Murex, as previously agreed

Provid Research: new Praecis chemistry division

Cardiovascular gene therapy focus of Cell Genesys-Mitotix agreement

New data confirms efficacy of Zomig

SWR-0035: new beta3-adrenoceptor agonist introduced at Japanese meeting

Fujisawa develops compound with submicromolar activity against H. pylori

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.